Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Tran

Showing results (121-130 of 181) with videos related to

Pageof 19
Sort By:
Liver Cancer|February 28, 2022
Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular CarcinomaLorenza Rimassa, Robin Kate Kelley, Tim Meyer, et al.
Plos One|April 25, 2012
The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver diseaseStéphanie Patouraux, Stéphanie Bonnafous, Cosmin S Voican, et al.
Hepatology (Baltimore, Md.)|January 14, 2025
CD44 in myeloid cells is a major driver of liver inflammation and injury in alcohol-associated liver diseaseDéborah Rousseau, Stéphanie Bonnafous, Frédéric Soysouvanh, et al.
Gastroenterology|March 29, 2011
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)Stéphane Chevaliez, Christophe Hézode, Alexandre Soulier, et al.
Hepatology (Baltimore, Md.)|February 15, 2019
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2)Markus Peck-Radosavljevic, Krzysztof Simon, Angelo Iacobellis, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
The mid-infrared spectroscopy: A novel non-invasive diagnostic tool for NASH diagnosis in severe obesityRodolphe Anty, Marie Morvan, Maëna Le Corvec, et al.
Journal of Hepatology|March 31, 2022
Endoplasmic reticulum-mitochondria miscommunication is an early and causal trigger of hepatic insulin resistance and steatosisAgathe Beaulant, Maya Dia, Bruno Pillot, et al.
Obesity Surgery|March 12, 2008
Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammationRodolphe Anty, Monsef Dahman, Antonio Iannelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2020
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaRobin Kate Kelley, Tim Meyer, Lorenza Rimassa, et al.
Gastroenterology|September 6, 2006
Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASHSoumeya Bekri, Philippe Gual, Rodolphe Anty, et al.
Pageof 19

Showing results (121-130 of 181) with videos related to

Sort By:
Pageof 19
Liver Cancer|February 28, 2022
Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular CarcinomaLorenza Rimassa, Robin Kate Kelley, Tim Meyer, et al.
Plos One|April 25, 2012
The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver diseaseStéphanie Patouraux, Stéphanie Bonnafous, Cosmin S Voican, et al.
Hepatology (Baltimore, Md.)|January 14, 2025
CD44 in myeloid cells is a major driver of liver inflammation and injury in alcohol-associated liver diseaseDéborah Rousseau, Stéphanie Bonnafous, Frédéric Soysouvanh, et al.
Gastroenterology|March 29, 2011
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)Stéphane Chevaliez, Christophe Hézode, Alexandre Soulier, et al.
Hepatology (Baltimore, Md.)|February 15, 2019
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2)Markus Peck-Radosavljevic, Krzysztof Simon, Angelo Iacobellis, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
The mid-infrared spectroscopy: A novel non-invasive diagnostic tool for NASH diagnosis in severe obesityRodolphe Anty, Marie Morvan, Maëna Le Corvec, et al.
Journal of Hepatology|March 31, 2022
Endoplasmic reticulum-mitochondria miscommunication is an early and causal trigger of hepatic insulin resistance and steatosisAgathe Beaulant, Maya Dia, Bruno Pillot, et al.
Obesity Surgery|March 12, 2008
Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammationRodolphe Anty, Monsef Dahman, Antonio Iannelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2020
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular CarcinomaRobin Kate Kelley, Tim Meyer, Lorenza Rimassa, et al.
Gastroenterology|September 6, 2006
Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASHSoumeya Bekri, Philippe Gual, Rodolphe Anty, et al.
Pageof 19